Global Surgical Lasers Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Surgical Lasers Market Size

• The global surgical lasers market size was valued at USD 8.48 billion in 2024 and is expected to reach USD 20.40 billion by 2032, at a CAGR of 11.60% during the forecast period
• This growth is driven by factors such as the increasing prevalence of chronic diseases requiring surgical intervention and the rising demand for minimally invasive procedures

Surgical Lasers Market Analysis

• Surgical lasers are precision instruments used in a wide range of medical procedures, including ophthalmology, dermatology, oncology, urology, and gynecology, offering minimal invasiveness and reduced recovery time
• The growth of this market is primarily driven by the increasing adoption of minimally invasive surgeries and the rising prevalence of chronic diseases such as cancer and cardiovascular disorders
• North America is expected to dominate the surgical lasers market with a market share of 42.5%, due to the region’s advanced healthcare infrastructure, high demand for minimally invasive surgical procedures, and a strong presence of leading medical device manufacturers
• Asia-Pacific is expected to be the fastest growing region in the surgical lasers market with a market share of 22.5%, during the forecast period due to the rapid expansion of healthcare infrastructure, increasing awareness of advanced surgical procedures, and rising surgical volumes across the region
• Solid-state lasers segment is expected to dominate the market with a market share of 39.9% due to its high precision, reliability, and versatility across various surgical applications

Report Scope and Surgical Lasers Market Segmentation

Surgical Lasers Market Trends

“Rapid Advancement in Laser Technologies”

• A key trend shaping the global surgical lasers market is the rapid advancement in laser technologies aimed at enhancing surgical precision and minimizing tissue damage
• New-generation lasers are being developed with improved wavelength specificity and energy control, allowing surgeons to perform highly targeted procedures with reduced recovery times and fewer complications
  • For instance, diode and CO₂ lasers are increasingly used in dermatology and oncology for their ability to precisely ablate tissue while preserving surrounding structures, making them ideal for both aesthetic and therapeutic applications beneficial for vitreoretinal surgeries and minimally invasive glaucoma procedures
• These innovations are significantly boosting the adoption of surgical lasers across multiple specialties, driving demand for safer, more efficient minimally invasive surgical solutions worldwide

Surgical Lasers Market Dynamics

Driver

“Increasing Demand for Minimally Invasive Procedures in Various Medical Specialties”

• The growing preference for minimally invasive procedures across various medical fields, including ophthalmology, dermatology, urology, and oncology, is a major driver of the global surgical lasers market
• Minimally invasive surgeries offer benefits such as reduced patient recovery times, lower risk of infection, and minimal scarring, which make them increasingly popular among both surgeons and patients. As surgical lasers are central to these procedures, the demand for advanced laser systems continues to rise
• In particular, laser treatments for conditions such as cancer, kidney stones, and skin resurfacing are seeing widespread adoption

For instance,

• In 2020, the global market for minimally invasive surgical procedures was valued at approximately USD 25.9 billion and is expected to grow substantially, driving further demand for surgical laser technologies to support these procedures

• This trend toward minimally invasive surgeries is expected to continue growing, further propelling the demand for surgical lasers in various medical disciplines

Opportunity

“Integration of AI and Machine Learning for Enhanced Precision in Surgical Procedures”

• The integration of AI and machine learning in surgical laser systems is creating new opportunities to enhance precision, reduce human error, and improve surgical outcomes across multiple medical specialties
• AI algorithms can analyze real-time laser treatment data, providing surgeons with enhanced insights and automated adjustments during procedures. This helps optimize laser parameters and adjust treatment protocols for individual patient needs, ensuring more effective and personalized care
• AI can also assist in predicting complications and adjusting laser settings in real-time, minimizing tissue damage and maximizing treatment success rates

For instance,

• In 2024, AI-powered surgical lasers were introduced in dermatology to assess skin lesions more accurately, enabling early detection and precise ablation. These systems can process high-definition images in real time, ensuring that treatments are tailored to the patient's specific condition

• The adoption of AI in surgical lasers is poised to revolutionize the market, improving patient outcomes, reducing recovery times, and enhancing the overall efficiency of surgical procedures

Restraint/Challenge

“High Equipment Costs Hindering Market Growth and Accessibility”

• The high cost of surgical laser systems remains a significant barrier to broader market adoption, particularly in developing regions and smaller healthcare facilities with limited budgets
• These advanced laser systems, which can range from tens of thousands to several hundred thousand dollars, pose financial challenges for hospitals, clinics, and outpatient centers looking to invest in cutting-edge technology
• Smaller healthcare providers often struggle to justify the significant capital investment in surgical lasers, which can delay or prevent them from upgrading equipment or incorporating new technologies into their practice

For instance,

• In February 2024, a district hospital in rural Maharashtra, India, postponed the procurement of a diode laser system used for urological procedures due to funding limitations. As a result, the facility continued relying on conventional surgical methods, impacting both the quality of care and the hospital’s plan to adopt minimally invasive technologies

• Consequently, this financial constraint can also lead to disparities in healthcare access and quality, as only well-funded institutions can afford to integrate the latest surgical laser technologies, potentially hindering market growth and accessibility

Surgical Lasers Market Scope

The market is segmented on the basis of type, procedure type, application, and end user.

In 2025, the solid-state lasers is projected to dominate the market with a largest share in type segment

The solid-state lasers segment is expected to dominate the surgical lasers market with the largest share of 39.9% in 2025 due to its high precision, reliability, and versatility across various surgical applications. These lasers offer superior beam quality and are widely used in ophthalmology, dermatology, and oncology. Their ability to deliver controlled energy with minimal damage to surrounding tissues makes them ideal for delicate procedures. In addition, ongoing advancements in solid-state laser technology continue to enhance their efficiency and clinical outcomes

The dermatology, is expected to account for the largest share during the forecast period in application market

In 2025, dermatology, segment is expected to dominate the market with the largest market share of 32.6% due to the growing demand for non-invasive cosmetic procedures such as skin resurfacing, hair removal, and scar reduction. The rising popularity of aesthetic treatments, driven by increased consumer awareness and disposable incomes, is fueling this growth. Advancements in laser technologies have improved safety, precision, and recovery times, making them more attractive to both patients and practitioners

Surgical Lasers Market Regional Analysis

“North America Holds the Largest Share in the Surgical Lasers Market”

• North America dominates the surgical lasers market with a market share of estimated 42.5%, driven, by the region’s advanced healthcare infrastructure, high demand for minimally invasive surgical procedures, and a strong presence of leading medical device manufacturers
• U.S. holds a market share of 68.3%, due to increased demand for surgical lasers in various specialties such as ophthalmology, dermatology, and oncology
• The presence of well-established reimbursement policies, a growing aging population, and high adoption rates of minimally invasive surgical techniques further strengthen the market’s position in North America
• In addition, the rapid growth of outpatient surgical centers and an increasing preference for laser-based treatments for conditions such as skin lesions, cancers, and eye diseases are contributing to the market expansion across the region

“Asia-Pacific is Projected to Register the Highest CAGR in the Surgical Lasers Market”

• Asia-Pacific is expected to witness the highest growth rate in the surgical lasers market with a market share of 22.5%, driven by the rapid expansion of healthcare infrastructure, increasing awareness of advanced surgical procedures, and rising surgical volumes across the region
• Countries such as China, India, and Japan are emerging as key markets due to the growing aging population, rising incidence of diseases requiring surgical intervention, and increasing demand for laser-based treatments
• Japan remains a leader in adopting advanced medical technologies, including surgical lasers, owing to its highly developed healthcare system and high rates of precision-driven surgeries in ophthalmology, dermatology, and oncology
• India is projected to register the highest CAGR of 12.3% in the surgical lasers market, driven by its expanding healthcare infrastructure, increasing healthcare spending, and growing prevalence of conditions requiring laser surgery

Surgical Lasers Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Lumenis Be Ltd. (Israel)
• Cynosure (U.S.)
• Alma Lasers (Israel)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• IPG Photonics Corporation (U.S.)
• Koninklijke Philips N.V. (U.S.)
• Candela Corporation (U.S.)
• biolitec Holding GmbH & Co KG (Austria)
• Fotona (Slovenia)
• LUTRONIC (South Korea)
• Carl Zeiss AG (Germany)
• Cutera, Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Alcon (Switzerland)
• Johnson & Johnson Services, Inc. (U.S.)
• El.En. S.p.A. (Italy)
• ASCLEPION (Germany)
• Iridex Corporation (U.S.)
• Plasma Surgical (U.S.)

Latest Developments in Global Surgical Lasers Market

• In March 2025, Alcon, the global leader in eye care pharmaceuticals, announced an agreement to acquire Lensar, a pioneer in cataract laser surgery. This acquisition is set to enhance Alcon’s femtosecond laser-assisted cataract surgery (FLACS) portfolio, integrating Lensar’s innovative ALLY system, which the company has previously described as a “revolutionary” advancement in the field
• In June 2024, Lumenis introduced Folix, a U.S. FDA-cleared fractional laser designed for hair loss treatment. This innovative laser stimulates hair follicles to promote regrowth while minimizing tissue damage, offering a non-invasive solution for both male and female pattern hair loss
• In February 2024, Biolase Inc. launched the Waterlase iPlus Premier Edition, an all-tissue laser system for dental procedures. This system features modular software with customizable procedure packages, enhanced user experience, and Wi-Fi connectivity, aiming to accelerate its adoption in dentistry
• In January 2024, DEKA, an Italian subsidiary of the El.En. Group, launched four new laser platforms under the "PRO" line. These platforms aim to transform traditional dermatological laser technology paradigms, cosmetic medicine, and dermatologic surgery
• In March 2021, Lumenis and Baring Private Equity Asia announced today that they have reached a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific for USD 1.07 billion, subject to closing adjustments. In Urology and ENT, the Surgical Business comprises laser and fibre technologies for less invasive surgical treatments

SKU-10776